ArticleVaccines2022
Meharry Medical College Mobile Vaccination Program: Implications for Increasing COVID-19 Vaccine Uptake among Minority Communities in Middle Tennessee.
Article in Vaccines, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
27 citing papers in PubMed.
- Optimizing mobile health clinic placement via geospatial modeling.Public health in practice (Oxford, England) · 2026Article
- Effectiveness of mobile vaccine clinics on COVID-19 vaccination uptake in the USA: an observational study.BMJ public health · 2026Article
- Vaccination models of delivery for refugees and migrants: a global scoping review.BMC public health · 2025Article
- Mobilizing COVID-19 Vaccination Partnerships for Newcomer Refugees and Immigrants in the Calgary, Canada Area, 2021-2022.Journal of immigrant and minority health · 2025Article
- Leveraging Ottawa Charter strategies to enhance COVID-19 vaccination: A systematic review of global health promotion approaches.Health promotion perspectives · 2025Review
- Covid-19 Vaccine Hesitancy and Under-Vaccination among Marginalized Populations in the United States and Canada: A Scoping Review.Journal of racial and ethnic health disparities · 2025Article
- Predicting mobile health clinic utilization for COVID-19 vaccination in South Carolina: A statistical framework for strategic resource allocation.PLOS global public health · 2025Article
- COVID-19 Vaccine Rollout Strategies in Utah from Local Health Departments' Perspectives: A Qualitative Analysis of Focus Group Discussions.Health equity · 2025Article
- Role of new vaccinators/pharmacists in life-course vaccination.Annals of medicine · 2024Review
- Mobile health clinics for distribution of vaccinations to underserved communities during health emergencies: A COVID-19 case study.Public health in practice (Oxford, England) · 2024Article
- Article
- Public Preference for Financing Preventive Vaccines in Health Shocks: The Case of COVID-19 Vaccines in a Middle-Income Country.PharmacoEconomics - open · 2024Article
- Respiratory Syncytial Virus Hospitalizations Associated With Social Vulnerability by Census Tract: An Opportunity for Intervention?Open forum infectious diseases · 2024Article
- An exploration of COVID-19 vaccination models for newcomer refugees and immigrants in Calgary, Canada.Archives of public health = Archives belges de sante publique · 2024Article
- Implementation of a mobile health clinic framework for Hepatitis C virus screening and treatment: a descriptive study.Lancet regional health. Americas · 2024Article
- Public health partnerships with faith-based organizations to support vaccination uptake among minoritized communities: A scoping review.PLOS global public health · 2024Article
- Mapping COVID vulnerability in relation to drug and alcohol recovery residence availability across the United States.BMC public health · 2023Article
- Motivational interview-based health mediator interventions increase intent to vaccinate among disadvantaged individuals.Human vaccines & immunotherapeutics · 2023Article
- Mixed messages and COVID-19 prevention: Why information isn't always enough to protect meat processing workers.AJPM focus · 2023Article
- Experiences, Enablers, and Challenges in Service Delivery and Integration of COVID-19 Vaccines: A Rapid Systematic Review.Vaccines · 2023Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
To end or curtail the COVID-19 pandemic, it is essential to incorporate mobile vaccination programs into the national vaccination strategy. Mobile COVID-19 vaccination programs play an important role in providing comprehensive vaccination from federally qualified institutions to underserved communities facing a higher risk for COVID-19 acquisition. The Meharry Medical College COVID-19 mobile vaccine program (MMC-MVP) has provided lifesaving COVID-19 vaccines, free of charge, to communities throughout Middle Tennessee. Mobile deployment is vital for those forced to travel long distances to get vaccinated and who have limited access to medical providers or vaccine clinics, lack access to public transportation, or may be homebound. The MMC-MVP, established on 13 April 2021, via funding from the Bloomberg Foundation, is sourced with infectious disease experts, nurse practitioners, and community engagement personnel to provide COVID-19 vaccinations and information in a culturally competent manner to diverse communities in Middle Tennessee. To provide broader access to COVID-19 vaccinations and vaccine-related information, the MMC-MVP partnered with the Tennessee Community Engagement Alliance, Vanderbilt University School of Nursing COVID-19 vaccine strike teams, non-academic, community-based organizations, and faith-based organizations. During the September 2021 COVID-19 surge in Tennessee, the MMC-MVP provided nearly 5000 free COVID-19 vaccinations to targeted, underserved communities. The MMC-MVP has provided vaccine equity in communities with the highest risk for acquiring COVID-19 and with greatest need in this pandemic.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.